1 unknown. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Unknown 1 |
Follow SKLB1028: new trials by email Literature Review of SKLB1028 trials Research Report on SKLB1028
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of SKLB1028 Versus Salvage Chemotherapy in Patients With Relapsed or Refractory (R/R) AML With FLT3-Mutated SKLB1028, Salvage Chemotherapy - Acute Myeloid Leukemia (AML) | Phase 3 | Unknown | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 315 | 2021-03-24 | 2021-11-02 |
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. (1)
China (1)